News & Views

Read the latest from Baszucki Group and its partners.

New Scientist: Keto diet shows real promise for anorexia recovery

June 3, 2026—Restricting carbohydrates may sound like an unlikely approach to treating anorexia, but following a ketogenic diet was linked to recovery in nearly 75 per cent of people with the eating disorder in a small trial

Read More

New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa

A pilot study published today in Communications Medicine demonstrates the potential of a new approach to treating anorexia nervosa — a disorder for which effective treatments have been significantly limited.

Read More

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy’s ability to improve patients’ mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness.

Read More

New Scientist: Why the keto diet could be a revolutionary way to treat mental illness

April 27, 2026—You may think of the high-fat, low-carb eating plan as a faddish way to lose weight. But the keto diet is now being used to tackle conditions from severe depression to bipolar disorder and anorexia, with transformative results.

Read More